Latest niche market research study on “Global Lumigan RC Market 2017 Industry Trend and Forecast 2021” published at Orbisresearch.com
Lumigan RC -API Insights, 2017 Report provides marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drug. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent, patent exclusivity information and competitive landscape. The research, analysis also presents the global sales data till 2016.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.
Request a sample of Lumigan RC-API Insights, 2017 @ http://www.orbisresearch.com/contacts/request-sample/233210 .
Scope of the Report
A review of the Lumigan RC based on information derived from company and industry-specific sources
Coverage of the Marketed data of the Lumigan RC on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
Patent Expiry Timeline and Exclusivity Details
Global Sales Figure from 2012-2016
Qualitative and quantitative assessment of market space
Reasons to buy
Evaluate the marketing status and exclusivity details of Lumigan RC to exploit opportunities for generic drug development opportunities.
Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Lumigan RC.
API intelligence over Lumigan RC and gaining primary intelligence over Active Ingredients manufacturers across the globe.
Uncovering opportunities in the rapidly growing the US market
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Purchase a copy of Lumigan RC-API Insights, 2017 @ http://www.orbisresearch.com/contact/purchase/233210 .
Table of Content in this Report:
Global Sales Assessment
Mechanism of Action
Marketed Details for the United States
Marketed Details for the Europe
Patent and Exclusivity Expiry Assessment United States (US)
Patent Numbers and Expiry Details
Global API Manufacturers Assessment
The United States Drug Master File (US DMF)
The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
The Active Pharmaceutical Ingredient (API) Manufacturers by Region
The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For More Press Releases, visit: http://orbisnewsrelease.com/